Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Sirturo. Always confirm against the full prescribing information.
100 interactions
Acebutolol
The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Bedaquiline.
Level 1 evidence
Acenocoumarol
The risk or severity of bleeding can be increased when Bedaquiline is combined with Acenocoumarol.
Level 2 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Bedaquiline.
Level 1 evidence
Adagrasib
The risk or severity of QTc prolongation can be increased when Adagrasib is combined with Bedaquiline.
Level 1 evidence
Adenosine
The risk or severity of QTc prolongation can be increased when Adenosine is combined with Bedaquiline.
Level 1 evidence
Albuterol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Bedaquiline.
Level 1 evidence
Alcaftadine
The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Bedaquiline.
Level 1 evidence
Alfuzosin
The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Bedaquiline.
Level 1 evidence
Amantadine
The risk or severity of QTc prolongation can be increased when Amantadine is combined with Bedaquiline.
Level 1 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Bedaquiline.
Level 1 evidence
Amiodarone
The metabolism of Bedaquiline can be decreased when combined with Amiodarone.
Level 1 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Amisulpride.
Level 1 evidence
Enter your NPI to unlock 1 major interaction for Sirturo
Sirturo (Bedaquiline Fumarate) has 356 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Sirturo (Bedaquiline Fumarate) has 10 major, 331 moderate, and 15 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Sirturo. Always confirm against the full prescribing information.